BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8388560)

  • 21. Low molecular weight heparins: prophylaxis of venous thromboembolism in surgical patients.
    Kakkar VV
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):9-19. PubMed ID: 9399405
    [No Abstract]   [Full Text] [Related]  

  • 22. European consensus statement on the prevention of venous thromboembolism. European Consensus Conference, Windsor, U.K., November, 1991.
    Haas S
    Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S5-8; discussion S9-10. PubMed ID: 8180330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Venous thromboembolism prophylaxis in medical patients: future perspectives.
    Imberti D; Prisco D
    Thromb Res; 2005; 116(5):365-75. PubMed ID: 16122549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
    Holzheimer RG
    Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery.
    Bergqvist D
    Br J Surg; 2004 Aug; 91(8):965-74. PubMed ID: 15286956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapeutic indications for acute venous thromboembolism. Current status and future perspectives].
    Prandoni P; Simioni P; Pagnan A
    Minerva Cardioangiol; 2003 Aug; 51(4):361-71. PubMed ID: 12900718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
    Hull RD; Pineo GF; Stein P
    Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost/benefit aspects on thromboprophylaxis.
    Bergqvist D; Mätzsch T
    Haemostasis; 1993 Mar; 23 Suppl 1():15-9. PubMed ID: 8388349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-doses of heparin in the prevention of deep vein thrombosis.
    Kakkar VV
    Bull Schweiz Akad Med Wiss; 1973 Nov; 29(4):235-43. PubMed ID: 4771352
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prevention of thromboembolism in digestive and abdominal surgery. New heparins].
    Samama M
    Ann Chir; 1992; 46(1):8-10. PubMed ID: 1312799
    [No Abstract]   [Full Text] [Related]  

  • 31. Low molecular weight heparins and external pneumatic compression as options for venous thromboembolism prophylaxis: a surgeon's perspective.
    Caprini JA; Arcelus JI; Traverso CI; Hasty JH
    Semin Thromb Hemost; 1991 Oct; 17(4):356-66. PubMed ID: 1666456
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of the cost of preventing postoperative deep vein thrombosis with either unfractionated or low molecular weight heparin.
    Bergqvist D; Lindgren B; Mätzsch T
    Br J Surg; 1996 Nov; 83(11):1548-52. PubMed ID: 9014669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economics of thromboprophylaxis in total hip replacement surgery.
    Harrison J; Warwick DJ; Coast J
    Pharmacoeconomics; 1997 Jul; 12(1):30-41. PubMed ID: 10169386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-molecular-weight heparins.
    Weitz JI
    N Engl J Med; 1997 Sep; 337(10):688-98. PubMed ID: 9278467
    [No Abstract]   [Full Text] [Related]  

  • 35. Current trends in the management of postsurgical thromboembolism: the role of low molecular weight heparin.
    Bergqvist D
    Semin Thromb Hemost; 1991 Oct; 17(4):332-5. PubMed ID: 1666452
    [No Abstract]   [Full Text] [Related]  

  • 36. Cost-effectiveness of venous thromboembolism prophylaxis in surgery.
    Bergqvist D
    Eur J Surg Suppl; 1994; (571):49-53. PubMed ID: 7519090
    [No Abstract]   [Full Text] [Related]  

  • 37. Cost-effectiveness of prophylaxis in total hip replacement.
    Paiement GD; Wessinger SJ; Harris WH
    Am J Surg; 1991 Apr; 161(4):519-24. PubMed ID: 1903606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New heparins--does it change prevention and treatment of venous thrombosis?].
    Ikkala E; Myllylä G
    Duodecim; 1993; 109(20):1753-9. PubMed ID: 7736998
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevention of venous thromboembolism after surgery: a review of enoxaparin.
    Bergqvist D; Lowe GD; Berstad A; Haas S; Hirsh J; Lassen MR; Samama M; Verhaeghe R
    Br J Surg; 1992 Jun; 79(6):495-8. PubMed ID: 1319256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Low molecular weight heparin (parnaparin) versus calcium heparin in the prevention of thromboembolic disease in general surgery].
    Gioè FP; Arcara M; Scaffidi Abbate F; Mercadante T
    Minerva Chir; 1994 Jun; 49(6):581-4. PubMed ID: 7970064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.